Osoyoos Cannabis Inc. (CSE:OSO) has launched its campaign on the Investing News Network’s Cannabis channel.

Osoyoos Cannabis is a company poised to process raw cannabis and produce cannabis extracts for Canada’s medicinal and adult-use markets. The company will generate revenue through third-party contract and toll processing, wholesaling of oils and distillates, white-label solutions and through selling Osoyoos Cannabis-branded products.


Osoyoos Cannabis has secured a lease with the Osoyoos Indian Band in Oliver, British Columbia (BC) for a cannabis extraction facility, which will be built out in two phases, the first of which is underway. Once the facility is fully operational, it will be able to process up to 100,000 kilograms of dried flower and produce approximately 9,800 kilograms of cannabis oil annually. The company has also re-submitted its processing license application to Health Canada through the Indigenous Navigator program, which the Company believes will help expedite the licensing process.

The company is also in discussions with the Osoyoos Indian Band to lease over 100 acres of land adjacent to the extraction facility for an outdoor cultivation site. The Okanagan has a hot, dry climate, which makes it an ideal location for outdoor cannabis cultivation.

Osoyoos Cannabis’ company highlights include the following:

  • CBD extracts market expected to reach $2.1 billion by 2020
  • Four-pronged revenue generation model
  • Re-submitted processing license to Health Canada through the Indigenous Navigator program, expediting the application process
  • In association with the Osoyoos Indian Band, a well-regarded and entrepreneurial band
  • Annual production of approximately 9,800 kilograms of cannabis oil once fully operational
  • Led by a strong and experienced management team and board of directors

Click here to see the educational profile for Osoyoos Cannabis Inc. (CSE:OSO) and to request an investor presentation.

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less

The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.

Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.

Keep reading... Show less

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .

Keep reading... Show less
  • On November 19 , the Mexican Senate passed comprehensive adult-use cannabis legalization, moving Mexico towards becoming one of the few countries to legalize cannabis nationally
  • On March 31, 2020 , the Company entered into an agreement with Tecnologico de Monterrey , the leading university in Mexico , to educate physicians across Latin America , in advance of the impending regulations in Mexico
  • To date, close to 550 LatAm physicians have obtained their diploma accrediting completion of Khiron’s medical education program
  • The Company plans to deploy its ZereniaTM medical cannabis clinics and telehealth strategy in Mexico , building on the success of its vertical integration strategy in Colombia
  • Expanding the Zerenia clinic strategy will build on the Company’s Colombia knowledge and proven distribution capabilities, with rapid telehealth service adoption and over 5,600 medical cannabis scripts filled to date
  • Mexico represents one of the largest potential markets for medical cannabis in the world and is anticipated to reach $1.2bn USD by 2028 (Prohibition Partners).
  • Company to release Q3 2020 financials and host webcast on Tuesday, December 1st

Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ), (OTCQX: KHRNF), ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe welcomes the passing of adult-use cannabis legislation by the Mexican Senate, which moves the country closer to a legalized cannabis market, and towards provision for medical cannabis products.  Khiron has had a presence in Mexico since 2018 and has been working with doctors and medical institutions to develop a deep understanding of the market.

Keep reading... Show less

Recap of special management call includes upcoming corporate milestones and details of proposed combination with established beverage manufacturer

Emerging leader in infused cannabis beverages, BevCanna Enterprises Inc. (CSE:BEV, OTCQB:BVNNF, FSE:7BC) (“BevCanna” or the “Company”) is pleased to provide a recorded recap of the special management call held on Tuesday November 24, 2020. The call discussed upcoming corporate milestones and reviewed recent developments at the developer and manufacturer of cannabinoid‐infused beverages and consumer products for in‐house brands and white label clients.

Keep reading... Show less